Inhibikase Therapeutics (IKT)
(Delayed Data from NSDQ)
$1.81 USD
-0.02 (-1.09%)
Updated May 24, 2024 03:59 PM ET
After-Market: $1.81 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.58 | 0.00% |
Earnings Summary
For their last quarter, Inhibikase Therapeutics (IKT) reported earnings of -$0.73 per share, beating the Zacks Consensus Estimate of $-0.79 per share. This reflects a positive earnings surprise of 7.59%. Look out for IKT's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.58 per share, reflecting a year-over-year increase of 47.75%.
Earnings History
Price & Consensus
Zacks News for IKT
New Strong Buy Stocks for February 13th
IKT: What are Zacks experts saying now?
Zacks Private Portfolio Services